PMC:7324763 / 72982-73497
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1167 | 0-4 | PR:000009196 | denotes | Jak1 |
T1168 | 7-17 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T1169 | 80-88 | SP_7 | denotes | COVID-19 |
T1170 | 107-118 | DG_41 | denotes | baricitinib |
T1171 | 191-195 | PR:000001393 | denotes | IL-6 |
T1172 | 273-284 | GO:0072583 | denotes | endocytosis |
T1173 | 402-413 | DG_41 | denotes | baricitinib |
T1174 | 497-505 | SP_7 | denotes | COVID-19 |
T91493 | 0-4 | PR:000009196 | denotes | Jak1 |
T58584 | 7-17 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T50670 | 80-88 | SP_7 | denotes | COVID-19 |
T22229 | 107-118 | DG_41 | denotes | baricitinib |
T68856 | 191-195 | PR:000001393 | denotes | IL-6 |
T24099 | 273-284 | GO:0072583 | denotes | endocytosis |
T60677 | 402-413 | DG_41 | denotes | baricitinib |
T73273 | 497-505 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T861 | 191-193 | Body_part | denotes | IL | http://purl.org/sig/ont/fma/fma86578 |
T862 | 255-263 | Body_part | denotes | clathrin | http://purl.org/sig/ont/fma/fma62262 |
T863 | 381-389 | Body_part | denotes | NK cells | http://purl.org/sig/ont/fma/fma63147 |
T864 | 384-389 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T503 | 80-88 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T504 | 221-233 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T505 | 422-442 | Disease | denotes | Rheumatoid Arthritis | http://purl.obolibrary.org/obo/MONDO_0008383 |
T506 | 497-505 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T895 | 296-297 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T896 | 381-389 | http://purl.obolibrary.org/obo/CL_0000623 | denotes | NK cells |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T4327 | 7-17 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T96858 | 191-193 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2037 | 0-6 | Gene | denotes | Jak1/2 | Gene:3716 |
2038 | 191-195 | Gene | denotes | IL-6 | Gene:3569 |
2039 | 89-97 | Species | denotes | patients | Tax:9606 |
2040 | 443-451 | Species | denotes | patients | Tax:9606 |
2041 | 506-514 | Species | denotes | patients | Tax:9606 |
2042 | 107-118 | Chemical | denotes | baricitinib | MESH:C000596027 |
2043 | 402-413 | Chemical | denotes | baricitinib | MESH:C000596027 |
2044 | 80-88 | Disease | denotes | COVID-19 | MESH:C000657245 |
2045 | 221-233 | Disease | denotes | inflammation | MESH:D007249 |
2046 | 422-442 | Disease | denotes | Rheumatoid Arthritis | MESH:D001172 |
2047 | 497-505 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T107 | 422-442 | Phenotype | denotes | Rheumatoid Arthritis | http://purl.obolibrary.org/obo/HP_0001370 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T172 | 221-233 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T173 | 255-284 | http://purl.obolibrary.org/obo/GO_0072583 | denotes | clathrin mediated endocytosis |
T174 | 273-284 | http://purl.obolibrary.org/obo/GO_0006897 | denotes | endocytosis |
MyTest
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32655581-32385052-34771842 | 318-321 | 32385052 | denotes | 241 |
32655581-30058112-34771843 | 453-456 | 30058112 | denotes | 250 |
TEST0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32655581-184-191-3171415 | 318-321 | ["32385052"] | denotes | 241 |
32655581-129-136-3171416 | 453-456 | ["30058112"] | denotes | 250 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32655581-32385052-34771842 | 318-321 | 32385052 | denotes | 241 |
32655581-30058112-34771843 | 453-456 | 30058112 | denotes | 250 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T440 | 0-133 | Sentence | denotes | Jak1/2 inhibitors (JAKi) are also undergoing clinical trials in moderate-severe COVID-19 patients, such as baricitinib (NCT04320277). |
T441 | 134-323 | Sentence | denotes | In addition to their ability to impede the production of IL-6, thus curb the excessive inflammation, they may also block clathrin mediated endocytosis–indicating a dual role for JAKi (241). |
T442 | 324-515 | Sentence | denotes | However, JAKi can also lead to the transient increase in NK cells as shown in baricitinib treated Rheumatoid Arthritis patients (250), which could be detrimental for severe COVID-19 patients. |